North Charleston, SC, United States of America

Aiye Liang

This inventor holds 3 USPTO granted patents. Top assignee: Virginia Commonwealth University. Active years: 2013-2015.


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Aiye Liang: Innovator in Therapeutic Oligomers

Introduction

Aiye Liang is a notable inventor based in North Charleston, SC (US). He has made significant contributions to the field of therapeutic oligomers, holding a total of 3 patents. His work focuses on the development of innovative compounds that have potential applications in treating various health conditions.

Latest Patents

Liang's latest patents include the development of cinnamic acid-based oligomers. These oligomers are designed for therapeutic uses, particularly as anti-inflammation agents, inhibitors of elastase, and antioxidants. In certain cases, such as the treatment of lung disorders like lung cancer, these compounds exhibit simultaneous beneficial activities. Specific subsets of these oligomers, such as β-O4 and β-5 trimers and tetramers, are also utilized as anticoagulants, showcasing their versatility in medical applications.

Career Highlights

Aiye Liang is affiliated with Virginia Commonwealth University, where he continues to advance his research and innovation in the field of therapeutic oligomers. His work has garnered attention for its potential impact on health and medicine.

Collaborations

Liang collaborates with esteemed colleagues, including Bruce D Spiess and John B Mangrum, who contribute to his research endeavors and enhance the scope of his work.

Conclusion

Aiye Liang's contributions to the field of therapeutic oligomers highlight his innovative spirit and dedication to improving health outcomes. His patents reflect a commitment to advancing medical science through novel compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…